Schedule 13G ownership disclosure

CorMedix Inc

COMMON STOCK, PAR V ALUE $0.001 PER SHARE · CUSIP: 21900C308

Event date: 2026-01-01

Filing-level shares
4,600,000.00
Percent of class
5.8%
  • SHAIBATALHAMD AYMEN ABDALKADER

    Shares: 4,600,000.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002063837-26-000001
Form type
SCHEDULE 13G/A
Filer
CorMedix Inc.
CIK
CIK 1410098
Filed
Jan 02, 2026
Reporting period
Jan 01, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub